# Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of Cerebral Hemorrhage

> **NCT05551923** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Hemorrhagic Stroke
- Acute
- Outcomes
- Metabolites
- Gut Microbiota

## Interventions

- **OTHER:** intestinal flora disturbance

## Key facts

- **NCT ID:** NCT05551923
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-14
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05551923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05551923, "Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of Cerebral Hemorrhage". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05551923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*